Australian warning over Trump’s drug plan
US President Donald Trump’s plan to deregulate drug approvals could allow unproven and even harmful new drugs to enter the Australian market, says an Australian expert.
Professor John Rasko, professor of medicine at the University of Sydney, says President Trump’s “extreme” view on the issue could potentially expose patients to toxic drugs.
“[Supporters] argue that potentially harmful drugs can be identified quickly after they go on sale,” says Professor Rasko.
However, this approach has been proven to be harmful, he says.
The TGA is due to fast-track drug approvals over the next two years based on approvals made by the US Food and Drug Administration.
In a co-authored article in the journal Nature, Professor Rasko referred to the cholesterol-lowering drug torcetrapib and the Alzheimer’s disease drug semagacestat, which were found